203 related articles for article (PubMed ID: 34091453)
21. Topical chlormethine gel in the treatment of mycosis fungoides: A single-center real-life experience and systematic review of the literature.
Laghi A; Franceschini C; Mandel VD; Teoli M; Musicco F; Sansone M; La Malfa AM; Ardigò M
Dermatol Ther; 2022 Sep; 35(9):e15683. PubMed ID: 35778940
[TBL] [Abstract][Full Text] [Related]
22. Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel.
Denis D; Beneton N; Laribi K; Maillard H
Cancer Manag Res; 2019; 11():2241-2251. PubMed ID: 30962713
[TBL] [Abstract][Full Text] [Related]
23. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
24. A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)-A Retrospective Cohort Study.
Querfeld C; Pacheco T; Haverkos B; Binder G; Angello J; Poligone B
Front Med (Lausanne); 2021; 8():679294. PubMed ID: 34277658
[TBL] [Abstract][Full Text] [Related]
25. [Necrotic leg ulcers after topical application of chlormethine].
Gary C; Gautier V; Lazareth I; Bagot M; Asgari R; Priollet P
Ann Dermatol Venereol; 2019 Mar; 146(3):226-231. PubMed ID: 30704945
[TBL] [Abstract][Full Text] [Related]
26. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
Liner K; Brown C; McGirt LY
Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
[TBL] [Abstract][Full Text] [Related]
27. Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
Benjamin Chase A; Markel K; Tawa MC
Clin J Oncol Nurs; 2015 Dec; 19(6):E131-9. PubMed ID: 26583648
[TBL] [Abstract][Full Text] [Related]
28. Chlormethine gel in combination with other therapies for treatment of mycosis fungoides: a review with patient cases.
Ardigò M; Nikbakht N; Teoli M; Gleason L; Crisan L; Querfeld C
Front Med (Lausanne); 2023; 10():1308491. PubMed ID: 38274457
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.
Tacastacas JD; Chan DV; Carlson S; Gerson SL; Dowlati A; Fu P; Lu K; Groft S; Rosenjack J; Honda K; McCormick TS; Cooper KD
JAMA Dermatol; 2017 May; 153(5):413-420. PubMed ID: 28199478
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of chlormethine gel in mycosis fungoides.
Guenova E; Ortiz-Romero PL; Poligone B; Querfeld C
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1739-1748. PubMed ID: 37262305
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and tolerability of chlormethine gel for the management of mycosis fungoides: a multicenter real-life evaluation.
Alberti-Violetti S; Ardigò M; Massone C; Pileri A; Sala R; Teoli M; Grandi V; Quaglino P; Pimpinelli N; Berti E
Front Oncol; 2023; 13():1298296. PubMed ID: 38239642
[TBL] [Abstract][Full Text] [Related]
32. Gelling Your Dermatology Nursing Practice: A Practical Guide for Managing the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
McCann SA; Chase AB; Tawa MC
J Dermatol Nurses Assoc; 2016 May; 8(3):180-192. PubMed ID: 28529678
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
34. Update on skin directed therapies in mycosis fungoides.
Lovgren ML; Scarisbrick JJ
Chin Clin Oncol; 2019 Feb; 8(1):7. PubMed ID: 30525757
[TBL] [Abstract][Full Text] [Related]
35. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
36. Excimer laser in the treatment of mycosis fungoides.
Deaver D; Cauthen A; Cohen G; Sokol L; Glass F
J Am Acad Dermatol; 2014 Jun; 70(6):1058-60. PubMed ID: 24775402
[TBL] [Abstract][Full Text] [Related]
37. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
38. Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations.
Crimp C; Gangal A; Tarabadkar ES; Shinohara MM
Cancer Manag Res; 2022; 14():3271-3279. PubMed ID: 36444357
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides.
Delfau-Larue MH; Dalac S; Lepage E; Petrella T; Wechsler J; Farcet JP; Bagot M
Blood; 1998 Nov; 92(9):3376-80. PubMed ID: 9787176
[TBL] [Abstract][Full Text] [Related]
40. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
Kim YH; Martinez G; Varghese A; Hoppe RT
Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]